ELANCO ANIMAL HEALTH INC (5EA.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:5EA • US28414H1032

20.995 EUR
-0.15 (-0.73%)
Last: Jan 23, 2026, 07:00 PM
Fundamental Rating

3

Taking everything into account, 5EA scores 3 out of 10 in our fundamental rating. 5EA was compared to 55 industry peers in the Pharmaceuticals industry. 5EA has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, 5EA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year 5EA was profitable.
  • 5EA had a positive operating cash flow in the past year.
  • 5EA had negative earnings in 4 of the past 5 years.
  • 5EA had a positive operating cash flow in 4 of the past 5 years.
5EA.DE Yearly Net Income VS EBIT VS OCF VS FCF5EA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

  • 5EA's Return On Assets of 0.27% is on the low side compared to the rest of the industry. 5EA is outperformed by 65.45% of its industry peers.
  • 5EA has a Return On Equity of 0.53%. This is in the lower half of the industry: 5EA underperforms 63.64% of its industry peers.
  • With a Return On Invested Capital value of 1.38%, 5EA is not doing good in the industry: 69.09% of the companies in the same industry are doing better.
  • Measured over the past 3 years, the Average Return On Invested Capital for 5EA is significantly below the industry average of 14.00%.
Industry RankSector Rank
ROA 0.27%
ROE 0.53%
ROIC 1.38%
ROA(3y)-2.13%
ROA(5y)-2.51%
ROE(3y)-5.1%
ROE(5y)-5.7%
ROIC(3y)1.73%
ROIC(5y)N/A
5EA.DE Yearly ROA, ROE, ROIC5EA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

  • 5EA has a worse Profit Margin (0.78%) than 61.82% of its industry peers.
  • 5EA's Profit Margin has improved in the last couple of years.
  • 5EA has a Operating Margin of 5.25%. This is in the lower half of the industry: 5EA underperforms 63.64% of its industry peers.
  • 5EA's Operating Margin has declined in the last couple of years.
  • The Gross Margin of 5EA (54.96%) is worse than 72.73% of its industry peers.
  • 5EA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.25%
PM (TTM) 0.78%
GM 54.96%
OM growth 3Y-3.95%
OM growth 5Y-14.04%
PM growth 3YN/A
PM growth 5Y28.06%
GM growth 3Y-0.22%
GM growth 5Y1.04%
5EA.DE Yearly Profit, Operating, Gross Margins5EA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 5EA is destroying value.
  • 5EA has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for 5EA has been increased compared to 5 years ago.
  • The debt/assets ratio for 5EA has been reduced compared to a year ago.
5EA.DE Yearly Shares Outstanding5EA.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
5EA.DE Yearly Total Debt VS Total Assets5EA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 1.48, we must say that 5EA is in the distress zone and has some risk of bankruptcy.
  • 5EA's Altman-Z score of 1.48 is on the low side compared to the rest of the industry. 5EA is outperformed by 69.09% of its industry peers.
  • 5EA has a debt to FCF ratio of 11.12. This is a negative value and a sign of low solvency as 5EA would need 11.12 years to pay back of all of its debts.
  • 5EA's Debt to FCF ratio of 11.12 is on the low side compared to the rest of the industry. 5EA is outperformed by 63.64% of its industry peers.
  • 5EA has a Debt/Equity ratio of 0.59. This is a neutral value indicating 5EA is somewhat dependend on debt financing.
  • 5EA has a Debt to Equity ratio (0.59) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 11.12
Altman-Z 1.48
ROIC/WACC0.16
WACC8.65%
5EA.DE Yearly LT Debt VS Equity VS FCF5EA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 2.40 indicates that 5EA has no problem at all paying its short term obligations.
  • The Current ratio of 5EA (2.40) is better than 80.00% of its industry peers.
  • A Quick Ratio of 1.23 indicates that 5EA should not have too much problems paying its short term obligations.
  • 5EA's Quick ratio of 1.23 is fine compared to the rest of the industry. 5EA outperforms 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 2.4
Quick Ratio 1.23
5EA.DE Yearly Current Assets VS Current Liabilites5EA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 12.94% over the past year.
  • 5EA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.01% yearly.
  • 5EA shows a small growth in Revenue. In the last year, the Revenue has grown by 3.08%.
  • The Revenue has been growing slightly by 7.65% on average over the past years.
EPS 1Y (TTM)12.94%
EPS 3Y-4.66%
EPS 5Y-3.01%
EPS Q2Q%46.15%
Revenue 1Y (TTM)3.08%
Revenue growth 3Y-2.33%
Revenue growth 5Y7.65%
Sales Q2Q%10.39%

3.2 Future

  • Based on estimates for the next years, 5EA will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.39% on average per year.
  • 5EA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.96% yearly.
EPS Next Y5.08%
EPS Next 2Y7.64%
EPS Next 3Y9.24%
EPS Next 5Y10.39%
Revenue Next Year5.5%
Revenue Next 2Y5.59%
Revenue Next 3Y5.48%
Revenue Next 5Y4.96%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
5EA.DE Yearly Revenue VS Estimates5EA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
5EA.DE Yearly EPS VS Estimates5EA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 26.24, the valuation of 5EA can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of 5EA is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 28.39, 5EA is valued at the same level.
  • With a Price/Forward Earnings ratio of 23.83, 5EA is valued on the expensive side.
  • 5EA's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.72, 5EA is valued at the same level.
Industry RankSector Rank
PE 26.24
Fwd PE 23.83
5EA.DE Price Earnings VS Forward Price Earnings5EA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 5EA's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 5EA is more expensive than 61.82% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as 5EA.
Industry RankSector Rank
P/FCF 34.49
EV/EBITDA 17.57
5EA.DE Per share data5EA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 5EA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.16
PEG (5Y)N/A
EPS Next 2Y7.64%
EPS Next 3Y9.24%

0

5. Dividend

5.1 Amount

  • 5EA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ELANCO ANIMAL HEALTH INC / 5EA.DE FAQ

Can you provide the ChartMill fundamental rating for ELANCO ANIMAL HEALTH INC?

ChartMill assigns a fundamental rating of 2 / 10 to 5EA.DE.


What is the valuation status for 5EA stock?

ChartMill assigns a valuation rating of 1 / 10 to ELANCO ANIMAL HEALTH INC (5EA.DE). This can be considered as Overvalued.


How profitable is ELANCO ANIMAL HEALTH INC (5EA.DE) stock?

ELANCO ANIMAL HEALTH INC (5EA.DE) has a profitability rating of 2 / 10.


How financially healthy is ELANCO ANIMAL HEALTH INC?

The financial health rating of ELANCO ANIMAL HEALTH INC (5EA.DE) is 3 / 10.